Loading…
90‐90‐90 – Charting a steady course to end the paediatric HIV epidemic
Introduction The new “90‐90‐90” UNAIDS agenda proposes that 90% of all people living with HIV will know their HIV status, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy and 90% of all people receiving antiretroviral therapy will have viral suppression by...
Saved in:
Published in: | Journal of the International AIDS Society 2015-12, Vol.18 (Suppl 6), p.20296-n/a |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c7636-2816bdc4fb048bd3d41cb1077698cc6c0f5e48785a9a0bc60081b068e3876353 |
---|---|
cites | cdi_FETCH-LOGICAL-c7636-2816bdc4fb048bd3d41cb1077698cc6c0f5e48785a9a0bc60081b068e3876353 |
container_end_page | n/a |
container_issue | Suppl 6 |
container_start_page | 20296 |
container_title | Journal of the International AIDS Society |
container_volume | 18 |
creator | Abrams, Elaine J Strasser, Susan |
description | Introduction
The new “90‐90‐90” UNAIDS agenda proposes that 90% of all people living with HIV will know their HIV status, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy and 90% of all people receiving antiretroviral therapy will have viral suppression by 2020. By focusing on children, the global community is in the unique position of realizing an end to the paediatric HIV epidemic.
Discussion
Despite vast scientific advances in the prevention and treatment of paediatric HIV infection over the last two decades, in 2014 there were an estimated 220,000 new paediatric infections attributed to mother‐to‐child HIV transmission (MTCT) and 150,000 HIV‐related paediatric deaths. Furthermore, adolescents remain at particularly high risk for acquisition of new HIV infections, and HIV/AIDS remains the second leading cause of death in this age group. Among the estimated 2.6 million children less than 15 years of age living with HIV infection, only 32% were receiving life‐saving antiretroviral treatment. After decades of languishing, good progress is now being made to prevent MTCT. Unfortunately, efforts to scale up HIV treatment services have been less robust for children and adolescents compared with adult populations. These discrepancies reflect substantial gaps in essential services and numerous missed opportunities to prevent HIV transmission and provide effective life‐saving antiretroviral treatment to children, adolescents and families. The road to an AIDS‐free generation will require bridging the gaps in HIV services and addressing the particular needs of children across the developmental spectrum from infancy through adolescence. To reach the ambitious new targets, innovations and service improvements will need to be rapidly escalated at each step along the prevention‐treatment cascade.
Conclusions
Charting a successful course to reach the 90‐90‐90 targets will require sustained political and financial commitment as well as the rapid implementation of a broad set of systematic improvements in service delivery. The prospect of a world where HIV no longer threatens the lives of infants, children and adolescents may finally be within reach. |
doi_str_mv | 10.7448/IAS.18.7.20296 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4670839</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A442906110</galeid><sourcerecordid>A442906110</sourcerecordid><originalsourceid>FETCH-LOGICAL-c7636-2816bdc4fb048bd3d41cb1077698cc6c0f5e48785a9a0bc60081b068e3876353</originalsourceid><addsrcrecordid>eNqNk91q2zAUgM3YWLtut7scgsHYjT3JlvVzMwhhXTMCu1jZrZDl41jFsTLL7shdH2HQN-yTTGmyzhkhKwbZWN_5ztHPiaLXBCecUvFhNvmWEJHwJMWpZE-iU8JzEacsT5-Ovk-iF95fYcxSQeXz6CRlLJOEyNNoLvHdza_dgO5ubtG01l1v2wXSyPegyzUybug8oN4haEvU14BWGkqr-84adDH7jmBlS1ha8zJ6VunGw6vd-yy6PP90Ob2I518_z6aTeWw4y1icCsKK0tCqwFQUZVZSYgqCOWdSGMMMrnKggotcS40LwzAWpMBMQCZCfJ6dRR-32tVQLKE00PadbtSqs0vdrZXTVu3PtLZWC3etKONYZDII3u8EnfsxgO_V0noDTaNbcINXhFMmOM5yEdC3_6BXYTfasDqVYcYZySVlx6g0lVhISlL8l1roBpRtKxeqM5vUasIJC-cUNuAoRWmwMUI2rvgAtYAWwoJdC5UNv_esj-HH_uQAH577gz6Y4FEB4wzvRgE16KavvWuG3rrW75uPggdqNp3zvoPq4UoQrDbdokK3KCIUV_fdEgLejC_SA_6nPQJAt8DPUPz6Pzr1ZTbZen8DZtoYrg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2290894120</pqid></control><display><type>article</type><title>90‐90‐90 – Charting a steady course to end the paediatric HIV epidemic</title><source>Publicly Available Content Database</source><source>Wiley Open Access Journals</source><source>PubMed Central</source><creator>Abrams, Elaine J ; Strasser, Susan</creator><creatorcontrib>Abrams, Elaine J ; Strasser, Susan</creatorcontrib><description>Introduction
The new “90‐90‐90” UNAIDS agenda proposes that 90% of all people living with HIV will know their HIV status, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy and 90% of all people receiving antiretroviral therapy will have viral suppression by 2020. By focusing on children, the global community is in the unique position of realizing an end to the paediatric HIV epidemic.
Discussion
Despite vast scientific advances in the prevention and treatment of paediatric HIV infection over the last two decades, in 2014 there were an estimated 220,000 new paediatric infections attributed to mother‐to‐child HIV transmission (MTCT) and 150,000 HIV‐related paediatric deaths. Furthermore, adolescents remain at particularly high risk for acquisition of new HIV infections, and HIV/AIDS remains the second leading cause of death in this age group. Among the estimated 2.6 million children less than 15 years of age living with HIV infection, only 32% were receiving life‐saving antiretroviral treatment. After decades of languishing, good progress is now being made to prevent MTCT. Unfortunately, efforts to scale up HIV treatment services have been less robust for children and adolescents compared with adult populations. These discrepancies reflect substantial gaps in essential services and numerous missed opportunities to prevent HIV transmission and provide effective life‐saving antiretroviral treatment to children, adolescents and families. The road to an AIDS‐free generation will require bridging the gaps in HIV services and addressing the particular needs of children across the developmental spectrum from infancy through adolescence. To reach the ambitious new targets, innovations and service improvements will need to be rapidly escalated at each step along the prevention‐treatment cascade.
Conclusions
Charting a successful course to reach the 90‐90‐90 targets will require sustained political and financial commitment as well as the rapid implementation of a broad set of systematic improvements in service delivery. The prospect of a world where HIV no longer threatens the lives of infants, children and adolescents may finally be within reach.</description><identifier>ISSN: 1758-2652</identifier><identifier>EISSN: 1758-2652</identifier><identifier>DOI: 10.7448/IAS.18.7.20296</identifier><identifier>PMID: 26639119</identifier><language>eng</language><publisher>Switzerland: International AIDS Society</publisher><subject>Acquired immune deficiency syndrome ; Adolescent ; Adolescents ; Adult ; AIDS ; AIDS (Disease) ; AIDS research ; AIDS treatment ; AIDS/HIV ; antiretroviral adherence ; Antiretroviral agents ; Antiretroviral drugs ; antiretroviral treatment ; Child ; Children ; Disease transmission ; Epidemics ; Epidemics - prevention & control ; Getting to 90-90-90 in paediatric HIV: What is needed? ; Highly active antiretroviral therapy ; HIV ; HIV infection in children ; HIV Infections - epidemiology ; HIV Infections - prevention & control ; Human immunodeficiency virus ; Humans ; Infant ; Malawi ; paediatric HIV ; Planning ; Prevention ; prevention of mother‐to‐child HIV transmission ; Public health administration ; Womens health</subject><ispartof>Journal of the International AIDS Society, 2015-12, Vol.18 (Suppl 6), p.20296-n/a</ispartof><rights>2015 Abrams E J et al; licensee International AIDS Society</rights><rights>COPYRIGHT 2015 International AIDS Society</rights><rights>COPYRIGHT 2015 John Wiley & Sons, Inc.</rights><rights>2015. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Abrams EJ and Strasser S; licensee International AIDS Society 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c7636-2816bdc4fb048bd3d41cb1077698cc6c0f5e48785a9a0bc60081b068e3876353</citedby><cites>FETCH-LOGICAL-c7636-2816bdc4fb048bd3d41cb1077698cc6c0f5e48785a9a0bc60081b068e3876353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3067615946/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3067615946?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11561,25752,27923,27924,37011,37012,44589,46051,46475,53790,53792,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26639119$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abrams, Elaine J</creatorcontrib><creatorcontrib>Strasser, Susan</creatorcontrib><title>90‐90‐90 – Charting a steady course to end the paediatric HIV epidemic</title><title>Journal of the International AIDS Society</title><addtitle>J Int AIDS Soc</addtitle><description>Introduction
The new “90‐90‐90” UNAIDS agenda proposes that 90% of all people living with HIV will know their HIV status, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy and 90% of all people receiving antiretroviral therapy will have viral suppression by 2020. By focusing on children, the global community is in the unique position of realizing an end to the paediatric HIV epidemic.
Discussion
Despite vast scientific advances in the prevention and treatment of paediatric HIV infection over the last two decades, in 2014 there were an estimated 220,000 new paediatric infections attributed to mother‐to‐child HIV transmission (MTCT) and 150,000 HIV‐related paediatric deaths. Furthermore, adolescents remain at particularly high risk for acquisition of new HIV infections, and HIV/AIDS remains the second leading cause of death in this age group. Among the estimated 2.6 million children less than 15 years of age living with HIV infection, only 32% were receiving life‐saving antiretroviral treatment. After decades of languishing, good progress is now being made to prevent MTCT. Unfortunately, efforts to scale up HIV treatment services have been less robust for children and adolescents compared with adult populations. These discrepancies reflect substantial gaps in essential services and numerous missed opportunities to prevent HIV transmission and provide effective life‐saving antiretroviral treatment to children, adolescents and families. The road to an AIDS‐free generation will require bridging the gaps in HIV services and addressing the particular needs of children across the developmental spectrum from infancy through adolescence. To reach the ambitious new targets, innovations and service improvements will need to be rapidly escalated at each step along the prevention‐treatment cascade.
Conclusions
Charting a successful course to reach the 90‐90‐90 targets will require sustained political and financial commitment as well as the rapid implementation of a broad set of systematic improvements in service delivery. The prospect of a world where HIV no longer threatens the lives of infants, children and adolescents may finally be within reach.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adolescent</subject><subject>Adolescents</subject><subject>Adult</subject><subject>AIDS</subject><subject>AIDS (Disease)</subject><subject>AIDS research</subject><subject>AIDS treatment</subject><subject>AIDS/HIV</subject><subject>antiretroviral adherence</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>antiretroviral treatment</subject><subject>Child</subject><subject>Children</subject><subject>Disease transmission</subject><subject>Epidemics</subject><subject>Epidemics - prevention & control</subject><subject>Getting to 90-90-90 in paediatric HIV: What is needed?</subject><subject>Highly active antiretroviral therapy</subject><subject>HIV</subject><subject>HIV infection in children</subject><subject>HIV Infections - epidemiology</subject><subject>HIV Infections - prevention & control</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infant</subject><subject>Malawi</subject><subject>paediatric HIV</subject><subject>Planning</subject><subject>Prevention</subject><subject>prevention of mother‐to‐child HIV transmission</subject><subject>Public health administration</subject><subject>Womens health</subject><issn>1758-2652</issn><issn>1758-2652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><recordid>eNqNk91q2zAUgM3YWLtut7scgsHYjT3JlvVzMwhhXTMCu1jZrZDl41jFsTLL7shdH2HQN-yTTGmyzhkhKwbZWN_5ztHPiaLXBCecUvFhNvmWEJHwJMWpZE-iU8JzEacsT5-Ovk-iF95fYcxSQeXz6CRlLJOEyNNoLvHdza_dgO5ubtG01l1v2wXSyPegyzUybug8oN4haEvU14BWGkqr-84adDH7jmBlS1ha8zJ6VunGw6vd-yy6PP90Ob2I518_z6aTeWw4y1icCsKK0tCqwFQUZVZSYgqCOWdSGMMMrnKggotcS40LwzAWpMBMQCZCfJ6dRR-32tVQLKE00PadbtSqs0vdrZXTVu3PtLZWC3etKONYZDII3u8EnfsxgO_V0noDTaNbcINXhFMmOM5yEdC3_6BXYTfasDqVYcYZySVlx6g0lVhISlL8l1roBpRtKxeqM5vUasIJC-cUNuAoRWmwMUI2rvgAtYAWwoJdC5UNv_esj-HH_uQAH577gz6Y4FEB4wzvRgE16KavvWuG3rrW75uPggdqNp3zvoPq4UoQrDbdokK3KCIUV_fdEgLejC_SA_6nPQJAt8DPUPz6Pzr1ZTbZen8DZtoYrg</recordid><startdate>201512</startdate><enddate>201512</enddate><creator>Abrams, Elaine J</creator><creator>Strasser, Susan</creator><general>International AIDS Society</general><general>John Wiley & Sons, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201512</creationdate><title>90‐90‐90 – Charting a steady course to end the paediatric HIV epidemic</title><author>Abrams, Elaine J ; Strasser, Susan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c7636-2816bdc4fb048bd3d41cb1077698cc6c0f5e48785a9a0bc60081b068e3876353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adolescent</topic><topic>Adolescents</topic><topic>Adult</topic><topic>AIDS</topic><topic>AIDS (Disease)</topic><topic>AIDS research</topic><topic>AIDS treatment</topic><topic>AIDS/HIV</topic><topic>antiretroviral adherence</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>antiretroviral treatment</topic><topic>Child</topic><topic>Children</topic><topic>Disease transmission</topic><topic>Epidemics</topic><topic>Epidemics - prevention & control</topic><topic>Getting to 90-90-90 in paediatric HIV: What is needed?</topic><topic>Highly active antiretroviral therapy</topic><topic>HIV</topic><topic>HIV infection in children</topic><topic>HIV Infections - epidemiology</topic><topic>HIV Infections - prevention & control</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infant</topic><topic>Malawi</topic><topic>paediatric HIV</topic><topic>Planning</topic><topic>Prevention</topic><topic>prevention of mother‐to‐child HIV transmission</topic><topic>Public health administration</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abrams, Elaine J</creatorcontrib><creatorcontrib>Strasser, Susan</creatorcontrib><collection>Wiley Open Access Journals</collection><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the International AIDS Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abrams, Elaine J</au><au>Strasser, Susan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>90‐90‐90 – Charting a steady course to end the paediatric HIV epidemic</atitle><jtitle>Journal of the International AIDS Society</jtitle><addtitle>J Int AIDS Soc</addtitle><date>2015-12</date><risdate>2015</risdate><volume>18</volume><issue>Suppl 6</issue><spage>20296</spage><epage>n/a</epage><pages>20296-n/a</pages><issn>1758-2652</issn><eissn>1758-2652</eissn><abstract>Introduction
The new “90‐90‐90” UNAIDS agenda proposes that 90% of all people living with HIV will know their HIV status, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy and 90% of all people receiving antiretroviral therapy will have viral suppression by 2020. By focusing on children, the global community is in the unique position of realizing an end to the paediatric HIV epidemic.
Discussion
Despite vast scientific advances in the prevention and treatment of paediatric HIV infection over the last two decades, in 2014 there were an estimated 220,000 new paediatric infections attributed to mother‐to‐child HIV transmission (MTCT) and 150,000 HIV‐related paediatric deaths. Furthermore, adolescents remain at particularly high risk for acquisition of new HIV infections, and HIV/AIDS remains the second leading cause of death in this age group. Among the estimated 2.6 million children less than 15 years of age living with HIV infection, only 32% were receiving life‐saving antiretroviral treatment. After decades of languishing, good progress is now being made to prevent MTCT. Unfortunately, efforts to scale up HIV treatment services have been less robust for children and adolescents compared with adult populations. These discrepancies reflect substantial gaps in essential services and numerous missed opportunities to prevent HIV transmission and provide effective life‐saving antiretroviral treatment to children, adolescents and families. The road to an AIDS‐free generation will require bridging the gaps in HIV services and addressing the particular needs of children across the developmental spectrum from infancy through adolescence. To reach the ambitious new targets, innovations and service improvements will need to be rapidly escalated at each step along the prevention‐treatment cascade.
Conclusions
Charting a successful course to reach the 90‐90‐90 targets will require sustained political and financial commitment as well as the rapid implementation of a broad set of systematic improvements in service delivery. The prospect of a world where HIV no longer threatens the lives of infants, children and adolescents may finally be within reach.</abstract><cop>Switzerland</cop><pub>International AIDS Society</pub><pmid>26639119</pmid><doi>10.7448/IAS.18.7.20296</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1758-2652 |
ispartof | Journal of the International AIDS Society, 2015-12, Vol.18 (Suppl 6), p.20296-n/a |
issn | 1758-2652 1758-2652 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4670839 |
source | Publicly Available Content Database; Wiley Open Access Journals; PubMed Central |
subjects | Acquired immune deficiency syndrome Adolescent Adolescents Adult AIDS AIDS (Disease) AIDS research AIDS treatment AIDS/HIV antiretroviral adherence Antiretroviral agents Antiretroviral drugs antiretroviral treatment Child Children Disease transmission Epidemics Epidemics - prevention & control Getting to 90-90-90 in paediatric HIV: What is needed? Highly active antiretroviral therapy HIV HIV infection in children HIV Infections - epidemiology HIV Infections - prevention & control Human immunodeficiency virus Humans Infant Malawi paediatric HIV Planning Prevention prevention of mother‐to‐child HIV transmission Public health administration Womens health |
title | 90‐90‐90 – Charting a steady course to end the paediatric HIV epidemic |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T22%3A33%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=90%E2%80%9090%E2%80%9090%20%E2%80%93%20Charting%20a%20steady%20course%20to%20end%20the%20paediatric%20HIV%20epidemic&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.au=Abrams,%20Elaine%20J&rft.date=2015-12&rft.volume=18&rft.issue=Suppl%206&rft.spage=20296&rft.epage=n/a&rft.pages=20296-n/a&rft.issn=1758-2652&rft.eissn=1758-2652&rft_id=info:doi/10.7448/IAS.18.7.20296&rft_dat=%3Cgale_pubme%3EA442906110%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c7636-2816bdc4fb048bd3d41cb1077698cc6c0f5e48785a9a0bc60081b068e3876353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2290894120&rft_id=info:pmid/26639119&rft_galeid=A442906110&rfr_iscdi=true |